Amal Therapeutics SA

Service, Biotechnology, Genf, Switzerland

Amal Therapeutics SA is a privately held Swiss biotech start-up company and a spin-off from the University of Geneva. Amal was incorporated on September 3rd 2012 and secured seed funding in February 2014 to establish and validate its technology platform. Boehringer Ingelheim Venture Fund led this ...

Nouscom AG

Manufacturer, Biotechnology, Basel, Switzerland

Nouscom is a private oncology company developing next generation immunotherapies. Nouscom's proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators. Nouscom is led by an ...

RocketVax AG

Manufacturer, Biotechnology, Basel, Switzerland

The company brings together both scientific and operational expertise from various institutions in Switzerland and Germany and aims to become a world leading centre of excellence for novel vaccine development. RocketVax has its foundation in the ties between Swiss Rockets AG, a Swiss incubator ...

Virometix AG

Manufacturer, Pharma, Schlieren, Switzerland

AMVAC AG

Manufacturer, Pharma, Zug, Switzerland

AmVac AG is a young Swiss-based biopharmaceutical company focusing on a particularly high-growth market segment within the high-yield pharmaceutical industry: Therapeutic vaccines with a focus on gynecology and urology.

Crucell / Berna Biotech Ltd

Manufacturer, Pharma, Bern, Switzerland

Crucell is a fully-integrated biopharmaceutical company. We focus on developing, producing and marketing products that combat infectious diseases. We are the largest independent vaccine company in the world. Headquartered in Leiden, The Netherlands, Crucell currently employs about 1100 people ...